about
Diabetes and cardiovascular disease: from evidence to clinical practice - position statement 2014 of Brazilian Diabetes Society.Adrenocortical production is associated with higher levels of luteinizing hormone in nonobese women with polycystic ovary syndromeBrazilian guidelines on prevention of cardiovascular disease in patients with diabetes: a position statement from the Brazilian Diabetes Society (SBD), the Brazilian Cardiology Society (SBC) and the Brazilian Endocrinology and Metabolism Society (SBNocturnal blood pressure fall as predictor of diabetic nephropathy in hypertensive patients with type 2 diabetes.Impact of insulin treatment in diabetic macular edema therapy in type 2 diabetes.IGF-1 Levels are Inversely Associated With Metabolic Syndrome in Obstructive Sleep Apnea.Willingness to pay as patient preference to bariatric surgery.Present Insights on Cardiomyopathy in Diabetic Patients.Emerging drugs for obesity therapy.Uric acid as a factor in the metabolic syndrome.In vitro and in vivo evidence for an indirect mechanism mediating enhanced aldosterone secretion by metoclopramide.Performance of two metabolic syndrome definitions in the estimation of cardiovascular disease among hypertensive patients.Diabetes guidelines may delay timely adjustments during treatment and might contribute to clinical inertia.Diuretic-induced potassium depletion and glucose intolerance are not related to hyperactivity of the renin-angiotensin-aldosterone system in hypertensive patients with the metabolic syndrome.Metabolic and haemodynamic effects of metformin in patients with type 2 diabetes mellitus and hypertension.Role of vasopressin in 24-hour blood pressure regulation in diabetic patients with autonomic neuropathy.Improved glycemic control by acarbose therapy in hypertensive diabetic patients: effects on blood pressure and hormonal parameters.Nitric oxide, cholesterol oxides and endothelium-dependent vasodilation in plasma of patients with essential hypertension.Effects of fluvastatin on insulin resistance and cardiac morphology in hypertensive patients.Association of carotid intima-media thickness and cardiovascular risk factors in women pre- and post-bariatric surgery.Cholesterol goal attainment in hypertensive patients: the impact of metabolic syndrome components.Effects of sibutramine on abdominal fat mass, insulin resistance and blood pressure in obese hypertensive patients.Effect of continuous positive airway pressure therapy on hypothalamic-pituitary-adrenal axis function and 24-h blood pressure profile in obese men with obstructive sleep apnea syndrome.X-PERT: weight reduction with orlistat in obese subjects receiving a mildly or moderately reduced-energy diet: early response to treatment predicts weight maintenance.The imbalance of sex-hormones related to depressive symptoms in obese men.Obstructive sleep apnea predisposes to nonalcoholic Fatty liver disease in patients with polycystic ovary syndrome.Is mandatory screening for obstructive sleep apnea with polysomnography in all severely obese patients indicated?Continuous positive airway pressure therapy improves hypoadiponectinemia in severe obese men with obstructive sleep apnea without changes in insulin resistance.Evaluation of quality of life in severely obese patients after bariatric surgery carried out in the public healthcare system.Reproducibility of ambulatory blood pressure monitoring in hypertensive patients with type 2 diabetes mellitus.Influence of autonomic neuropathy upon left ventricular dysfunction in insulin-dependent diabetic patients.Relation of asymmetrical dimethylarginine levels with renal outcomes in hypertensive patients with and without type 2 diabetes mellitus.Postprandial adiponectin levels are associated with improvements in postprandial triglycerides after Roux-en-Y gastric bypass in type 2 diabetic patients.Obesity Metabolic and Hormonal Disorders Associated with Obstructive Sleep Apnea and Their Impact on the Risk Of Cardiovascular Events.Association of endothelial dysfunction with cardiovascular risk factors and new-onset diabetes mellitus in patients with hypertension.Lipid peroxidation and antioxidants in hyperlipidemia and hypertension.Lean and fat mass loss in obese patients before and after Roux-en-Y gastric bypass: a new application for ultrasound technique.The impact of metabolic parameters on clinical response to VEGF inhibitors for diabetic macular edema.Role of Bradykinin in Insulin Sensitivity and Blood Pressure Regulation During HyperinsulinemiaAltered blood pressure profile, autonomic neuropathy and nephropathy in insulin-dependent diabetic patients
P50
Q33647298-5D34869D-EE06-4852-ABC2-7301EEAEDDB4Q33661717-1FD62CD1-7ECB-4C70-8992-D91A7A858F77Q33908782-3F6104E7-5740-4B2C-8184-13078E412C5CQ34086137-D3C3FA18-6C52-475A-A21D-089B31B70713Q35007582-47587237-43D3-4F8C-AC45-27C098E26DFDQ36696004-73015BEE-7D5B-43A4-88AE-29FD33912DC9Q37332991-1819C38E-8BD1-4033-ACF4-4F8D8AD135DEQ37402793-F0A42B8E-CDD5-4CE7-97FD-229716A8257FQ37494328-2D0170EB-DFCA-4CB4-A3B0-F7A7AB96051DQ37738006-C2FF9921-E27B-4F33-9F7C-CED0A339D272Q42452420-D822AC82-C107-4014-AA61-501EA926359EQ42942647-CA075BC2-FBA1-4A0D-A171-B55472C06AB0Q42949426-5FBF1BDF-5FC4-41FF-9547-A7CBD617356FQ43264445-401B1D70-389F-4A14-99B2-FA12E0BD3E43Q43795772-E3DDC9D8-32CB-4711-B58A-0891D9A12ABCQ43874849-C3F39B52-3434-46B8-9737-8C9DEFBA3CB2Q44107437-52DA5F07-B6D0-4836-8914-FF19FC3C8635Q44212643-6AF55DF5-9346-4679-836C-592E88F5A8D6Q45071766-C5FF31ED-5854-4EC1-B4EE-A7E9D539AA97Q46072555-A82F9320-3A73-48EB-8470-737DAB34715FQ46229489-91C64F01-ED9C-492F-BC07-87163204CBDAQ46422665-E334D705-285A-4CDD-A174-E78AF0717D75Q46560194-FAD937E8-0C7F-4D29-AE8B-565B6A2D63B7Q46747380-81D99AA1-72BE-4A0C-B652-0E80C3590E21Q48072143-BF8FB9A8-644D-47C9-8C47-545E97FA9854Q48143160-DD24FD0D-1E90-43A1-A088-220A5EE480A7Q48300324-C59AE186-A65E-45EB-891C-EBB291B77BF1Q48396369-5349F7E4-591B-41D7-BCF8-F0991477D510Q48461107-98158D1B-73A8-41B9-89B4-71882B81FDB1Q48473685-5869E0EE-678A-4D10-A485-175519ADBE8DQ48722498-B5D015FB-597C-4951-982B-CF6E3C83388DQ49342596-EAEC27A2-E905-4DFD-80D3-CAB93E3351ABQ50928422-56DED58C-9AC6-4C98-88C8-31705637C81CQ51740647-DDFD437A-8EFF-4EC5-ABC6-D9C0EC567E4FQ52617084-27058938-2C4C-442C-A8C3-5997BEC5F635Q53871958-A95BEA00-DDB8-47C8-A8CF-46BA271F221BQ54054513-5A0878BA-560E-4DFE-A4C9-E803272F4179Q54390287-5F471394-72A5-4373-84DB-15B5746DD488Q62090266-2CA583D2-76A3-4DF0-96BE-1A818A47D917Q73050703-4D748121-1734-4EC1-AB18-5881540DBADE
P50
description
researcher
@en
wetenschapper
@nl
name
M T Zanella
@en
M T Zanella
@nl
type
label
M T Zanella
@en
M T Zanella
@nl
prefLabel
M T Zanella
@en
M T Zanella
@nl
P106
P31
P496
0000-0002-8451-8522